Marja Pasanen

RSS feed of this list

  1. Pharmacogenetics of SLCO1B1: Population genetics and effect on statins

    Pasanen, M., 2008

    Research output: ThesisDoctoral ThesisCollection of Articles

  2. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake

    Niemi, M., Pasanen, M. & Neuvonen, P. J., 2011, In : Pharmacological Reviews. 63, 1, p. 157-181 25 p.

    Research output: Contribution to journalReview ArticleScientificpeer-review

  3. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

    Keskitalo, J., Pasanen, M. K., Neuvonen, P. J. & Niemi, M., 2009, In : Pharmacogenomics. 10, 10, p. 1617-1624 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  4. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans

    Xiang, X., Yi, H., Neuvonen, M., Pasanen, M. K., Kalliokoski, A., Backman, J. T., Laitila, J., Neuvonen, P. J. & Niemi, M., 2009, In : Pharmacogenetics and Genomics. 19, 6, p. 447-457 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  5. Global analysis of genetic variation in SLCO1B1

    Pasanen, M. K., Neuvonen, P. J. & Niemi, M., 2008, In : Pharmacogenomics. 9, 1, p. 19-33 15 p.

    Research output: Contribution to journalArticleScientificpeer-review

  6. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate

    Pasanen, M. K., Miettinen, T. A., Gylling, H., Neuvonen, P. J. & Niemi, M., 2008, In : Pharmacogenetics and Genomics. 18, 10, p. 921-926 6 p.

    Research output: Contribution to journalArticleScientificpeer-review

  7. Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin

    Pasanen, M. K., Fredrikson, H., Neuvonen, P. J. & Niemi, M., 2007, In : Clinical Pharmacology and Therapeutics. 82, 6, p. 726-733 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  8. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

    Niemi, M., Pasanen, M. K. & Neuvonen, P. J., 2006, In : Clinical Pharmacology and Therapeutics. 80, 4, p. 356-366 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  9. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics

    Niemi, M., Arnold, K., Backman, J. T., Pasanen, M. K., Gödtel-Armbrust, U., Wojnowski, L., Zanger, U., Neuvonen, P. J., Eichelbaum, M., Kivistö, K. T. & Lang, T., 2006, In : Pharmacogenetics and Genomics. 16, 11, p. 801-808 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  10. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

    Pasanen, M. K., Neuvonen, M., Neuvonen, P. J. & Niemi, M., 2006, In : Pharmacogenetics and Genomics. 16, 12, p. 873-879 7 p.

    Research output: Contribution to journalArticleScientificpeer-review

Previous 1 2 Next